Table 1 Correlation between ANRIL expression and clinicopathological characteristics in hepatocellular carcinoma
Clinical parameter | ANRIL | Chi-square test P value | |
|---|---|---|---|
High no. cases | Low no. cases | Â | |
Age (years) | Â | Â | 0.850 |
  <50 | 23 | 8 |  |
  >50 | 35 | 11 |  |
Gender | Â | Â | 0.608 |
  Male | 46 | 14 |  |
  Female | 12 | 5 |  |
Drinking state | Â | Â | 0.932 |
  Yes | 36 | 12 |  |
  No | 22 | 7 |  |
HBV | Â | Â | 0.713 |
  Yes | 50 | 17 |  |
  No | 8 | 2 |  |
Cirrhosis | Â | Â | 0.155 |
  Yes | 46 | 17 |  |
  No | 12 | 2 |  |
AFP | Â | Â | 0.625 |
  ≤20 | 18 | 8 |  |
  20–400 | 19 | 6 |  |
  ≥400 | 21 | 5 |  |
Tumor size | Â | Â | <0.01 |
  ≤3 cm | 11 | 9 |  |
  3–5 cm | 13 | 9 |  |
  5–10 cm | 31 | 1 |  |
  ≥10 cm | 3 | 0 |  |
BCLC stage | Â | Â | <0.01 |
  0 | 2 | 2 |  |
  A | 19 | 15 |  |
  B | 37 | 2 |  |